Search Results

You are looking at 1 - 3 of 3 items for

  • Author: S Birken x
  • Refine by access: All content x
Clear All Modify Search
S Birken
Search for other papers by S Birken in
Google Scholar
PubMed
Close
,
MA Gawinowicz
Search for other papers by MA Gawinowicz in
Google Scholar
PubMed
Close
,
Y Maydelman
Search for other papers by Y Maydelman in
Google Scholar
PubMed
Close
, and
Y Milgrom
Search for other papers by Y Milgrom in
Google Scholar
PubMed
Close

The gonadotropins are a family of closely related heterodimeric glycoprotein hormones homologous in structure to disulfide-knot growth factors. Metabolic proteolytic processing in vivo of this disulfide cross-linked region results in urinary excretion of a residual highly stable core structure. The primary structure of the pituitary form of the hLH beta core was reported earlier, but it has proved difficult to isolate the urinary core, although antibodies to the pituitary core demonstrated its presence. By conventional and immunoaffinity methods, the urinary core has been isolated and its structure determined by both chemical and mass spectrometric methods. The urinary hLH beta core is the same as the pituitary-extracted hLH beta core, beta 6-40 disulfide bridged to beta 55-93, except that the pituitary core is more heterogeneous containing also beta 49-93. These findings imply a dual origin of urinary cores, both directly from a secreting tissue and by kidney processing of circulating hormone. We also found that pregnant chimpanzees excrete a CG beta core with a primary structure identical to that of the human CG beta core of pregnancy. In conclusion, gonadotropin core generation and urinary excretion of nearly identical gonadotropin metabolites is common among primates. Although possible biological functions of these core fragments remain unproven, they have diagnostic utility because of their stability and abundance.

Free access
G Kovalevskaya
Search for other papers by G Kovalevskaya in
Google Scholar
PubMed
Close
,
S Birken
Search for other papers by S Birken in
Google Scholar
PubMed
Close
,
T Kakuma
Search for other papers by T Kakuma in
Google Scholar
PubMed
Close
, and
JF O'Connor
Search for other papers by JF O'Connor in
Google Scholar
PubMed
Close

Human chorionic gonadotropin (hCG) exhibits molecular heterogeneity in both its protein and carbohydrate moieties. This communication describes changes in hCG isoforms detected directly in clinical samples. These isoforms, quantified in blood or urine specimens, show a progression of change throughout normal pregnancy. Early pregnancy produces a type of hCG that resembles, in terms of immunoreactivity, a major form of hCG excreted in choriocarcinoma. The isoforms predominate for the first 5-6 weeks of gestation and then diminish, being replaced with the hCG isoforms which predominate throughout the remainder of pregnancy. The alteration in hCG isoform content occurs in both blood and urine. The progression of isoforms is best delineated by calculating the change in the ratio of the two forms, as many hCG assays either do not detect or fail to discriminate among these isoforms. An analogous pattern of hCG isoforms was observed in patients with in vitro fertilization pregnancies. hCG isolated from the pituitary displayed binding characteristics similar to those of the hCG derived from normal pregnancy urine. The early pregnancy hCG isoforms appear to have a differential expression in normal pregnancy as opposed to pregnancies which will not carry to term, suggesting that a determination of the relative balance of hCG isoforms may have diagnostic application in predicting pregnancy outcome.

Free access
G Kovalevskaya
Search for other papers by G Kovalevskaya in
Google Scholar
PubMed
Close
,
S Birken
Search for other papers by S Birken in
Google Scholar
PubMed
Close
,
T Kakuma
Search for other papers by T Kakuma in
Google Scholar
PubMed
Close
,
N Ozaki
Search for other papers by N Ozaki in
Google Scholar
PubMed
Close
,
M Sauer
Search for other papers by M Sauer in
Google Scholar
PubMed
Close
,
S Lindheim
Search for other papers by S Lindheim in
Google Scholar
PubMed
Close
,
M Cohen
Search for other papers by M Cohen in
Google Scholar
PubMed
Close
,
A Kelly
Search for other papers by A Kelly in
Google Scholar
PubMed
Close
,
J Schlatterer
Search for other papers by J Schlatterer in
Google Scholar
PubMed
Close
, and
JF O'Connor
Search for other papers by JF O'Connor in
Google Scholar
PubMed
Close

Human chorionic gonadotropin (hCG) glycoforms change as pregnancy progresses. We have developed an antibody (B152) which can measure a hyperglycosylated early pregnancy isoform of hCG. This putative hyperglycosylated form of hCG arises very early in pregnancies and is rapidly replaced by an isoform that predominates for the remainder of the pregnancy. The profiles of these hCG glycoforms are measured as a ratio of values of two immunometric assays. The profiles of these ratios differ between pregnancies which persist and those which will experience early failure. In this report, daily urine hCG isoform ratios from donor eggs (no exogenous hCG pretreatment), in vitro fertilization pregnancies were profiled and analyzed from the first day following embryo transfer (ET). Significant differences were found between continuing pregnancy and pregnancy loss throughout days 5-20 post-ET. When hCG isoform ratios were analyzed from the first day of detectable hCG, pregnancy loss could be predicted in the case of a single fetus both during the 5- to 10-day time segment (P=0.018) and the 10- to 15-day time segment (P=0.045). When single and multiple fetus pregnancies were analyzed together significance was approached in the 10- to 15-day time period (P=0.058). In a second population of pregnant women who conceived naturally, in whom urine samples were collected at approximately weekly intervals to either term birth or clinical spontaneous abortion, the ratio could discriminate between miscarriages and normal term pregnancies (P=0.043). In later pregnancy, the ratio of hCG isoforms declined more rapidly in miscarriages than in term pregnancy. Antibody B152 was produced using a choriocarcinoma-derived hCG (C5), which was hyperglycosylated at both N- and O-linked sites and was 100% nicked at position beta(47-48). Western blot analyses supported the assay results showing that early pregnancy urine does not contain nicked C5-like hCG. Also, the early pregnancy hCG appeared to be the same size as later pregnancy hCG as judged by SDS gel electrophoresis. A series of Western blot analyses and immunoassays conducted with the samples either non-reduced or reduced showed that B152 is directed to a linear epitope located in the COOH-terminal peptide region of the beta subunit. This indicated that only the O-glycan groups and not the N-linked glycans are part of the antibody epitope.

Free access